Computerworld announced that “IBM’s Watson Health artificial intelligence unit has signed a two-year joint-development agreement with the U.S. Food and Drug Administration (FDA) to explore using blockchain technology to securely share patient data for medical research and other purposes.” The January 11, 2017 article entitled “IBM Watson, FDA to explore blockchain for secure patient data exchange” included this plan for blockchain:

IBM Watson Health and the FDA will explore the exchange of patient-level data from several sources, including electronic medical records (EMRs), clinical trials, genomic data, and health data from mobile devices, wearables and the “Internet of Things.” The initial focus will be on oncology-related information.

Given the importance of ERMs this is significant and helps promote the value of blockchain.